RPh on the Go Wins for Youth

by pharmacy on September 9, 2014

Steve Sidell is the Director of Quality Assurance and Compliance at RPh on the Go. He began his career as a pharmacist prior to joining RPh on the Go 15 years ago. He is an avid biker, with about 37 years of fitness, sport, and transportation cycling under his belt. A little over a week ago, he tackled the legendary Col du Tourmalet climb in France… and prevailed!

win4youth-adecco

Steve Sidell (farthest right) is pictured here with his Adecco North America Win4Youth colleagues at the Col du Tourmalet event in France.

Steve completed the climb as part of Adecco Group North America’s Win4Youth initiative  which translates kilometers logged in cycling into donations to youth charities around the world. RPh on the Go, which operates as part of Adecco Group NA, nominated Steve as a Win4Youth ambassador in April 2014. Steve’s rigorous training schedule, love for cycling, and lifelong dream to complete the Col du Tourmalet made  him the best candidate for this role.

More than 80 Adecco colleagues representing 36 countries participated in this year’s Win4Youth main event which took place at the Col du Tourmalet in the French Pyrenees, a “hors catagorie” climb, meaning the most difficult of all. The “big climb” began at an elevation of 2000+ ft. and ended at well over 6000 ft.

On Sunday, August 30, 2014,  80 Win4Youth ambassadors embarked on the climb, which every single ambassador successfully completed. Adecco CEO Patrick De Maeseneire stood at the finish line to congratulate each and every one of them.

“It is very difficult to put into words the feeling of accomplishment and pride that welled up in my chest as he shook my hand,” Steve said about completing the legendary climb. “As I said when asked for a comment, ‘This was the greatest thing I ever did.’”

On behalf of RPh on the Go, we’d like to thank and congratulate Steve for his amazing contributions to Win4Youth and for representing RPh on the Go in the best way possible!

Click here to watch the official Adecco Win4Youth Main Event video.

{ 0 comments }

September: National Preparedness Month

by pharmacy on September 3, 2014

national-preparedness-month

If there was an emergency in your local area right now, would you be ready? The Centers for Disease Control and Prevention (CDC) want you to focus on being ready for anything at anytime – and that’s what September is all about. 2014 is the 11th year for the National Preparedness Month – sponsored by the Federal Emergency Management Agency in the U.S. Department of Homeland Security. [click to continue…]

{ 0 comments }

FDA Approves Topical Antifungal for Toenails

by pharmacy on August 27, 2014

Jublia-antifungalIn June, Valeant Pharmaceuticals International Inc. announced FDA approval for their medication Jublia, or efinaconazole. The topical solution is approved for the treatment of toenail onychomycosis as a result of either Trichophyton rubrum or Trichophyton mentagrophytes. [click to continue…]

{ 0 comments }

August is National Immunization Awareness Month

by pharmacy on August 20, 2014

national-immunization-awareness-monthAugust is National Immunization Awareness Month. It’s the perfect time to discuss immunizations with patients who come in to pick up their regular prescriptions. Many people are under the impression that vaccines are just for children, but the fact is that adults are just as susceptible to many conditions. Vaccinations are important year round, not just during flu season. Several immunizations, such as the tetanus shot, require boosters every 10 years. Adults who suffered chicken pox as a child will benefit from a shingles vaccination. [click to continue…]

{ 0 comments }

FDA Approves Inhaled Insulin

by pharmacy on August 6, 2014

Afrezza-Technosphere-insulinIn late June, MannKind Corp. announced the FDA approved their product, an inhaled form of insulin, known as Afrezza. [click to continue…]

{ 0 comments }

Coumadin Injection Recalled

by pharmacy on July 30, 2014

coumadin-injectionIn July, Bristol-Myers Squibb announced the recall of some of their 5 mg single-use Coumadin injections. Six lots are affected in the recall: 00201125, 00201126, 00201127, 00201128, 00201129, and 00201130. The voluntary nationwide recall is a result of visible particulate matter found in some unreleased samples. These lots were distributed in six-count cartons to pharmacies from November 2011 through January 2014. The expiration dates stagger from September 2014 until September 2015. [click to continue…]

{ 0 comments }

© RPh on the Go, All Rights Reserved.